Skip navigation

Following FDA resignation, what's next for hemp CBD?

Outgoing Commissioner Gottlieb spoke of “pathway” to hemp CBD as a dietary ingredient

FDA commissioner Scott Gottlieb’s resignation announcement was greeted with uncertainty among supplement industry figures gathered in Anaheim for Natural Products Expo West, with many questioning what to expect from the agency’s efforts toward clarity around hemp CBD.

Register to view the full article

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.